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Abstract
Alcelaphine herpesvirus 1 (AlHV-1) is a γ-herpesvirus (γ-HV) belonging to the macavirus
genus that persistently infects its natural host, the wildebeest, without inducing any clinical
sign. However, cross-transmission to other ruminant species causes a deadly lymphoproli-
ferative disease named malignant catarrhal fever (MCF). AlHV-1 ORF73 encodes the
latency-associated nuclear antigen (LANA)-homolog protein (aLANA). Recently, aLANA
has been shown to be essential for viral persistence in vivo and induction of MCF, suggest-
ing that aLANA shares key properties of other γ-HV genome maintenance proteins. Here
we have investigated the evasion of the immune response by aLANA. We found that a gly-
cin/glutamate (GE)-rich repeat domain was sufficient to inhibit in cis the presentation of an
epitope linked to aLANA. Although antigen presentation in absence of GE was dependent
upon proteasomal degradation of aLANA, a lack of GE did not affect protein turnover. How-
ever, protein self-synthesis de novo was downregulated by aLANA GE, a mechanism
directly associated with reduced antigen presentation in vitro. Importantly, codon-modifica-
tion of aLANA GE resulted in increased antigen presentation in vitro and enhanced induction
of antigen-specific CD8+ T cell responses in vivo, indicating that mRNA constraints in GE
rather than peptidic sequence are responsible for cis-limitation of antigen presentation.
Nonetheless, GE-mediated limitation of antigen presentation in cis of aLANA was dispens-
able during MCF as rabbits developed the disease after virus infection irrespective of the
expression of full-length or GE-deficient aLANA. Altogether, we provide evidence that
inhibition in cis of protein synthesis through GE is likely involved in long-term immune eva-
sion of AlHV-1 latent persistence in the wildebeest natural host, but dispensable in MCF
pathogenesis.
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Author summary
The macavirus alcelaphine herpesvirus 1 (AlHV-1) is a γ-herpesvirus (γ-HV) that has been
first isolated in East-Africa in 1960 from a wildebeest and identified to be the etiological
agent of malignant catarrhal fever (MCF) in bovine. An interesting aspect of AlHV-1 is
that it can persist in wildebeest by remaining latent whereas it induces MCF upon cross-
species transmission in several species of ruminants including cattle. MCF is a deadly lym-
phoproliferative disease developing after a prolonged incubation period. We have recently
demonstrated that viral genome maintenance by the latency-associated viral protein
aLANA is essential for inducing MCF. In the present study, we have investigated the ability
of aLANA to evade antigen-specific cytotoxic T lymphocytes, an important property of γ-
HV genome maintenance proteins to enable long term virus persistence. We provide evi-
dence that GE, a specific repeated region in the nucleotidic sequence of aLANA, is directly
involved in restraining aLANA protein synthesis. Although the lack of GE in aLANA did
not significantly affect MCF induction in the rabbit model, such mechanism resulted in
severely reduced presentation of an antigenic peptide linked to aLANA in a model in vitro
and ineffective induction of antigen-specific CD8+ T lymphocyte responses in vivo. These
results are important as they suggest that immune evasion of aLANA during MCF in sus-
ceptible species is not essential in the pathogenesis of the disease but identified GE to be
essential for immune evasion during latency, likely in the wildebeest natural host.
Introduction
Infection with the members of the Herpesviridae family is characterized with lifelong persis-
tence of the viral genomes in the infected hosts. Such latent infection is only possible through
the establishment of complex immune evasion mechanisms. Latent infection by γ-herpesvi-
ruses (γ-HV) is mostly asymptomatic and mainly occurs in lymphoid cells. However, γ-HV
latency can induce lymphoproliferative diseases and cancers. As such, Epstein-Barr virus
(EBV) infection of immunocompromised human individuals has been associated with naso-
pharyngeal carcinoma, Burkitt’s and Hodgkin’s lymphomas and Kaposi’s sarcoma associated-
herpesvirus (KSHV) has been associated with primary effusion lymphomas, Castleman’s dis-
ease and Kaposi’s sarcoma [1–3]. In addition, lymphoproliferative diseases are caused by other
γ-HVs in specific cases of cross-species transmission [4, 5]. The development of such malig-
nancies has been related to γ-HV latent infection. Latent infection of host cells by many γ-HVs
is dependent upon the expression of a viral genome maintenance protein (GMP), which
ensures the persistence of the viral episome within actively dividing cells, yet simultaneously
evades the immune surveillance. Interestingly, specific EBNA1 and LANA1 peptides have
been shown to be presented by cross-priming and specific CD8+ T cells could be readily iso-
lated from EBV- or KSHV-infected individuals [6–8]. In addition, recent reports investigating
the immune evasion mechanisms by γ-HV GMPs suggest that latently infected cells evade the
detection by host CD8+ cytotoxic T lymphocytes (CTLs) rather by a limitation of antigen pre-
sentation than an absence of T cell epitopes.
Malignant catarrhal fever (MCF) is an acute, sporadic and fatal pan-systemic lymphoproli-
ferative disease of a variety of species of the Artiodactyla order, including cattle. The main
causative agents of MCF are two γ-HVs that are grouped in the macavirus genus, ovine herpes-
virus 2 (OvHV-2) and alcelaphine herpesvirus 1 (AlHV-1). These viruses cause no apparent
disease in their natural host species. Sheep are naturally infected by OvHV-2, which is respon-
sible for the sporadic sheep-associated form of MCF [5]. Wildebeest are persistently infected
aLANA immune evasion
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with AlHV-1, the causative agent of the wildebeest-derived form of the disease [9, 10]. The
prevalence of AlHV-1 infection in wildebeest is close to 100% and transmission to MCF-sus-
ceptible species mainly occurs during the calving period and in the first months of life [11, 12].
MCF impact on the local pastoralist populations has largely been underestimated, with recent
reports demonstrating that MCF is perceived to be the cattle disease with the highest economic
and social impacts in these areas [13–16]. In addition, MCF has been reported throughout the
world in game farms or zoological collections where mixed ruminant species including wilde-
beest are kept [17].
Recent data demonstrated that MCF is caused by the activation and proliferation of latently
infected CD8+ T cells [18–20] and that the expression of the AlHV-1 genome maintenance
protein, the latency-associated nuclear antigen (LANA)-homolog (aLANA) encoded by the
ORF73 gene of AlHV-1 is essential for both viral persistence in infected hosts and induction of
MCF [21]. The expression of aLANA is abundant in the tissues of MCF-developing animals
and should potentially induce an anti-viral cytotoxic response. Although such anti-viral
response might exist, it is however not protective. Many γ-HVs genome maintenance proteins
have cis-acting immune evasion mechanisms mainly, but not only, regulated by their large
acidic repeat domains [22–29]. A common feature of γ-HV GMPs is their evasion of specific
CTLs through cis-acting but diverse mechanisms [30–34].
Here we have investigated the immune evasion properties of aLANA. We showed that a gly-
cin/glutamate (GE)-rich repeat domain in aLANA was necessary and sufficient to inhibit the
presentation by MHC-I of an epitope linked to it. We further found that aLANA GE downre-
gulated protein self-synthesis and this mechanism could be associated with reduced antigen
presentation in vitro. Importantly, codon modification of the purine bias in GE resulted in
heightened antigen presentation of an epitope linked to aLANA and heightened induction of
antigen-specific CD8+ T cell responses. These results suggested that inhibition in cis of antigen
presentation is controlled by mRNA constraints in GE and reduced protein translation effi-
ciency. Nonetheless, infection of rabbits with an AlHV-1 recombinant strain expressing a GE-
deficient aLANA protein did not affect MCF induction, suggesting a dispensable role of cis-
acting immune evasion by aLANA in the pathogenesis of MCF. These findings enlarge our
understanding of MCF pathogenesis and suggest that cis-acting immune evasion by aLANA is
likely involved in long-term viral persistence in latently infected wildebeests.
Results
Limited presentation of a CD8+ T cell epitope linked in cis to alcelaphine
herpesvirus 1 aLANA
Sequencing of the AlHV-1 genome revealed that its ORF73 gene encodes a 1300 amino acid-
long protein [35], which makes AlHV-1 LANA-homolog protein (aLANA) the longest GMP
ortholog described to date among rhadinoviruses and macaviruses. Analysis of the primary
structure of aLANA revealed the presence of a long central repeat (CR) region that could be
divided in two main subregions based on the abundance of glycine, proline and glutamate
(GPE-rich region) or glycine and glutamate residues (GE-rich region). An additional region
containing glutamate repeats is enclosed within the GE-rich region, and was termed the E-rich
region (Fig 1A). We hypothesized that aLANA possesses mechanisms inhibiting antigen pre-
sentation in cis similar to other γ-HV GMPs and therefore renders AlHV-1 latently infected
cells difficult to detect by cytotoxic T cells. We used the SIINFEKL peptide of chicken ovalbu-
min as cognate epitope to be linked in frame to eGFP and transient expression in 293Kb cells
for detection of H-2Kb-peptide complexes [36]. In this model, 293Kb cells constitutively
express the murine H-2Kb MHC class I haplotype. 293Db cells were used as controls to
aLANA immune evasion
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determine the specificity of the staining (S1A Fig). In order to determine the capability of
aLANA to inhibit antigen presentation in cis, we introduced AlHV-1 ORF73 coding sequence
Fig 1. Cis-acting inhibition of antigen presentation of aLANA. (A) Peptidic coding sequence of aLANA. The acidic central repeat region is highlighted.
Residues in red represent the region rich in glycin, glutamate, and proline, consequently termed GPE. Residues in blue represent the region rich in glutamate
consequently named E. Residues in green represent the region rich in glycin and glutamate and consequently named GE. The GE-rich domain comprises the
E-rich region. N- and C-terminal regions of aLANA are in black. (B) Schematic description of expression constructs. The expression plasmid peGFP-C1
(eGFP) was used to fuse a H-2Kb-restricted ovalbumin CTL epitope, SIINFEKL, in-frame to a C-terminal enhanced Green Fluorescent Protein (eGFP-SIIN).
The aLANA coding sequence was then inserted in-frame to the eGFP-SIIN plasmid leaving the SIINFEKL in the C-terminus end of aLANA (aLANA-SIIN) or in
the N-terminus end of aLANA (SIIN-aLANA) to allow analysis of endogenous processing of aLANA. (C) Representative results from flow cytometry analysis
of SIINFEKL presentation on 293Kb cells. Cells were stained with APC-conjugated anti-mouse H-2Kb-SIINFEKL complex (25-D1.16) 48h after transfection
with the indicated constructs. Numbers in red boxes indicate percent of H-2Kb-SIINFEKL-positive cells within eGFP+ cells. (D) Percent of eGFP+ cells
expressing H-2Kb-SIINFEKL complexes at the cell surface based on the analysis in C. (E) The SIINFEKL-specific T cell hybridoma B3Z was co-cultured
overnight with 293Kb cells 48h after transfection with the different constructs. β-galactosidase activity was assayed by cell lysis in the presence of
chlorophenol-red-β-D-galactoside (CPRG) and absorbance read at 595 nm. Values relative to eGFP negative construct are shown. (F) Confocal analysis of
cell surface expression of H-2Kb-SIINFEKL expression 48h after transfection of 293Kb cells with the different constructs. Scale bar = 5 μm. (G)
Representative results from flow cytometry analysis of SIINFEKL presentation on 293Kb cells 48h after co-transfection with the SIIN construct and plasmids
expressing MuHV-4 K3 protein (mK3) that degrades MHC class I heavy chains, or a aLANA-V5 fusion protein [21]. (H) Percent of eGFP+ cells expressing H-
2Kb-SIINFEKL complexes at the cell surface based on the analysis in G. Bars show mean ± S.D. (n = 3). Statistical analyses by one-way ANOVA and
Dunnett’s post-test with SIIN as control comparison mean (***p0.001).
https://doi.org/10.1371/journal.ppat.1006691.g001
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into the peGFP-SIIN plasmid to generate vectors expressing aLANA-SIIN and SIIN-aLANA
proteins (Fig 1B). 293Kb cells transiently expressing aLANA-SIIN or SIIN-LANA expressed
very low amounts of MHC-epitope complexes at the cell surface and were poorly recognized
by SIINFEKL-specific B3Z hybridoma cells (Fig 1C–1F). Similar results were also obtained
using L929Kb and VeroKb cell lines (S1B and S1C Fig). These results suggested poor antigen
processing. There was no evidence for aLANA inhibiting peptide presentation from co-trans-
fected eGFP-SIIN (Fig 1G and 1H). These results suggested an immune evasion mechanism by
aLANA acting in cis and not in trans.
The central repeat region of aLANA is involved in cis-acting inhibition of
antigen presentation
To identify possible contributions of the CR region in aLANA reduced antigen presentation,
we constructed a mutant form of aLANA from which the entire CR domain was removed. The
resulting ΔCR aLANA mutant protein was inserted into the peGFP-SIIN expression vector in
order to express the ΔCR-SIIN protein (Fig 2A). The expression of MHC-epitope complexes at
the cell surface of 293Kb cells transiently expressing ΔCR-SIIN was rescued to levels similar to
the SIIN positive control (Fig 2B and 2C). ΔCR-SIIN expression was restricted to the nuclei
like the full-length form of aLANA (S2 Fig). Also, 293Kb cells expressing ΔCR-SIIN or SIIN
induced similar levels of β-galactosidase activity in B3Z (Fig 2D). These results suggested that
antigen processing of aLANA is impaired by the presence of the CR region.
A key region of aLANA for cis-acting inhibition of MHC class I-restricted
epitope presentation
Next, we investigated potential contributions of the subregions of the CR domain in limiting
antigen presentation in cis. First, we produced two forms of the aLANA protein lacking either
the GPE domain (ΔGPE-SIIN) or the purine-enriched GE domain (ΔGE-SIIN), respectively
(Fig 3A). 293Kb cells expressing ΔGPE-SIIN showed intranuclear localization of eGFP expres-
sion (S2 Fig) and strongly reduced antigen presentation at the cell surface as well as reduced
B3Z activation (Fig 3B–3D). ΔGE-SIIN expression in 293Kb cells was also intranuclear (S2
Fig), but strikingly resulted in rescued peptide presentation and activation of B3Z cells to levels
similar to the SIIN control (Fig 3B–3D). Thus, the GE subregion of aLANA impaired antigen
processing and presentation of a peptide linked to it. Supporting this conclusion, similar
results could be observed in VeroKb cells (S1C Fig) and also using plasmid vectors in which
protein expression is driven by an eukaryotic EF1-α promoter (S1D Fig). Next, we investigated
the role of the E-rich domain within the GE region of aLANA as well as both flanking subre-
gions named GE1 and GE2, respectively (Fig 4A). We produced four additional constructs
expressing different combinations of the GE subregions, namely ΔE-, ΔGE1-, ΔGE2-, and
ΔEΔGE2-SIIN. Expression of these mutant forms of aLANA in 293Kb cells did not reach the
levels of antigen presentation obtained with ΔGE-SIIN (Fig 4B–4E), suggesting that the entire
GE region is necessary for limiting antigen presentation in cis.
aLANA GE-rich domain is sufficient for limiting antigen presentation in
cis
To examine the possibility that the GE-rich domain is self-sufficient to inhibit the presentation
of a linked epitope, we expressed a chimeric protein composed in N-terminus of the eGFP
coding sequence fused with the GE domain and a C-terminal SIINFEKL epitope tag (Fig 5A,
GE-SIIN). To further investigate if the position of the SIINFEKL peptide could affect its
aLANA immune evasion
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presentation, another construct consisted in the insertion of an additional SIINFEKL epitope
tag in between eGFP and GE (Fig 5A, SIIN-GE-SIIN). Following transfection of 293Kb cells,
expression of both GE-SIIN and SIIN-GE-SIIN could be detected in both cytoplasm and
nucleus and antigen presentation was strongly limited by the presence of the GE domain (Fig
5B and 5C). These results demonstrated that the GE domain is sufficient to significantly reduce
antigen presentation.
Proteasomal degradation of aLANA and turnover
In order to decipher how GE inhibits cis-peptide presentation, we first examined the effect of
proteasome inhibition on antigen presentation (Fig 6A). 293Kb cells were transfected to
express eGFP, SIIN, aLANA, ΔCR-SIIN, ΔGPE-SIIN or ΔGE-SIIN before treatment with the
proteasome inhibitor MG132 and detection of H-2Kb-SIINFEKL complexes at the cell surface
by flow cytometry. MG132 treatment resulted in a severe reduction of antigen presentation for
Fig 2. Deletion of the central repeat region of aLANA restores OVA-peptide presentation. (A)
Schematic description of aLANA expression constructs. The full central repeat region was truncated from
aLANA to generate a ΔCR-SIIN construct. (B) Representative results from flow cytometry analysis of
SIINFEKL presentation on 293Kb cells 48h after transfection with the indicated constructs. Numbers in red
boxes indicate percent of H-2Kb-SIINFEKL-positive cells within eGFP+ cells. (C) Percent of eGFP+ cells
expressing H-2Kb-SIINFEKL complexes at the cell surface based on the analysis in B. (D) β-galactosidase
activity in B3Z after overnight co-culture with 293Kb cells 48h after transfection with the indicated constructs.
Bars show mean ± S.D. (n = 3). Statistical analyses by one-way ANOVA and Dunnett’s post-test with
aLANA-SIIN as control comparison mean (**p0.01, ***p0.001).
https://doi.org/10.1371/journal.ppat.1006691.g002
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all constructs. Although MG132 mainly targets the proteasome, it can also affect autophagy
pathways [37]. Thus, treatments using more specific lactacystin or epoxomicin were per-
formed and resulted in significantly reduced detection of the H-2Kb-SIINFEKL complexes
(Fig 6B and S3 Fig). However, treatments with rapamycin, chloroquine or 3 methyladenine
(3-MA) did not affect antigen presentation. These results confirmed that GE-dependent inhi-
bition of antigen presentation is dependent upon proteasomal degradation, whereas activation
or inhibition of autophagy pathways did not affect peptide presentation. Inhibition of γ-HV
GMPs epitope presentation by their respective central repeats has been attributed to reduced
protein synthesis and reduced protein degradation [22]. To analyze the implication of the CR
and GE regions in protein turnover, we first used a cycloheximide (CHX)/chase experiment at
24h after transfection (Fig 6C) and observed that the levels of proteins up to 30h after CHX
treatment were not significantly affected in absence of CR or GE. In an alternative approach,
we used the HaloTag technology to generate fusion proteins of aLANA, ΔCR and ΔGE. 293Kb
cells were transfected with aLANA-, ΔCR- or ΔGE-HaloTag constructs and pulse-labeled
overnight with the HaloTag TMR-Direct ligand. The cells were then washed and chased for
72h and fluorescence intensities were recorded over time (Fig 6D). All constructs showed
similar turnover suggesting that the CR or GE regions are not involved in reduced protein
degradation.
The aLANA GE-rich domain regulates protein translation and RNA
transcription levels
Steady-state levels of protein expression were first investigated using immunoblotting of total
cell lysates 48h after transfection with plasmids encoding aLANA-, ΔCR-, ΔGPE- or ΔGE-SIIN
(Fig 7A). We observed that the absence of both CR and GE regions resulted in increased pro-
tein expression levels. In addition, we observed increased eGFP fluorescence intensities over
time in absence of GE and at similar transfection efficiencies (Fig 7B). Thus, GE might regulate
Fig 3. Deletion of the GE-rich domain of aLANA restores OVA-peptide presentation. (A) Schematic description of the aLANA expression constructs
deleted for the GPE or GE-rich domains, to generate the ΔGPE-SIIN and ΔGE-SIIN constructs. (B) Representative results from flow cytometry analysis of
SIINFEKL presentation on 293Kb cells 48h after transfection with the indicated constructs. Numbers in red boxes indicate percent of H-2Kb-SIINFEKL-
positive cells within eGFP+ cells. (C) Percent of eGFP+ cells expressing H-2Kb-SIINFEKL complexes at the cell surface based on the analysis in B. (D) β-
galactosidase activity in B3Z after overnight co-culture with 293Kb cells 48h after transfection with the indicated constructs. Bars show mean ± S.D. (n = 3).
Statistical analyses by one-way ANOVA and Dunnett’s post-test with aLANA-SIIN as control comparison mean (**p0.01, ***p0.001).
https://doi.org/10.1371/journal.ppat.1006691.g003
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the level of protein expression. A pulse-chase labeling experiment was conducted to further
address this hypothesis (Fig 7C). At 12h post-transfection of aLANA-, or ΔGE-HaloTag con-
structs, cells were pulse-labeled overnight with the HaloTag TMR-Direct ligand to label all
transfected cells and chased for a further 24h. Then, de novo synthesized proteins were labeled
with the HaloTag Oregon-Green (OG) ligand. We observed increased proportions of OG-pos-
itive cells over time in cells expressing ΔGE-HaloTag, suggesting that GE regulates the effi-
ciency of protein synthesis. Next, we sought to directly investigate translation efficiency of
aLANA-, ΔCR-, ΔGPE- or ΔGE-SIIN using an uncoupled in vitro translation assay (Fig 7D).
Molar equivalents of capped RNA obtained from in vitro transcription using T7 RNA poly-
merase were translated in vitro using a rabbit reticulocyte lysate system. Although multiple
bands could be observed for some constructs (S4B Fig), analysis of the intensity of the bands at
the expected sizes (S4A Fig) suggested lower translation levels of aLANA and ΔGPE, while
Fig 4. The entire GE-rich domain is necessary to inhibit the presentation of a linked-peptide. (A) Schematic description of the aLANA expression
constructs deleted for the E, GE1 and GE2 domains, to generate the ΔE-SIIN, ΔGE1-SIIN, ΔGE2-SIIN, and ΔEΔGE2-SIIN constructs. (B) Representative
results from flow cytometry analysis of SIINFEKL presentation on 293Kb cells 48h after transfection with the indicated constructs. Numbers in red boxes
indicate percent of H-2Kb-SIINFEKL-positive cells within eGFP+ cells. (C) Percent of eGFP+ cells expressing H-2Kb-SIINFEKL complexes at the cell surface
based on the analysis in B. (D) β-galactosidase activity in B3Z after overnight co-culture with 293Kb cells 48h after transfection with the indicated constructs.
(E) Confocal analysis of cell surface expression of H-2Kb-SIINFEKL expression 48h after transfection of 293Kb cells with the different constructs. Scale
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ΔCR and ΔGE showed higher translation efficiencies. Translation of SIIN was used as positive
control and the negative control consisted of no RNA. These results suggested that the GE
domain downregulates aLANA translation efficiency. In addition, immunoblotting of total cell
lysates after transfection with SIIN, aLANA-SIIN or GE-SIIN expression vectors demonstrated
that the GE domain was self-sufficient to significantly decrease protein steady-state levels after
transfection of 293Kb cells (Fig 7E).
To further investigate whether the GE domain could also regulate transcription, we quanti-
fied steady-state RNA expression levels in 293Kb cells transfected with aLANA-, ΔCR-, ΔGPE-
or ΔGE-SIIN. Interestingly, aLANA and ΔGPE transfected cells had similar low levels of spe-
cific transcripts whereas the absence of the CR or GE domains in aLANA resulted in signifi-
cantly enhanced transcription levels (Fig 8A). Such increase of RNA expression was not due to
decreased turnover of ORF73 mRNA as aLANA, ΔCR and ΔGE had similar RNA abundance
after actinomycin D treatment following transfection (Fig 8B).
Regulation to low-level protein expression by the GE-rich domain is
associated with low presentation of linked antigenic peptide
The limited presentation efficiency of CD8+ T cell epitopes from EBNA1 has been suggested to
be primarily determined by low translation efficiency rather than its intracellular stability [23,
29]. These observations were in line with the main hypothesis according to which defective
ribosomal products (DRiPs) generated during protein synthesis rather than mature proteins
are the major source of antigens that are processed to MHC class I [38–40]. The absence of the
GE domain resulted in increased steady-state levels of aLANA protein expression that was
related to increased translation efficiency and increased steady-state RNA levels (Figs 7 and 8),
Fig 5. The GE-rich domain of aLANA is sufficient to regulate OVA-peptide presentation. (A) Schematic representation of peGFP-C1 expression
constructs to generate the GE-SIIN and SIIN-GE-SIIN expression constructs. The GE-rich domain was inserted in-frame between the eGFP coding
sequence and the SIINFEKL tag (GE-SIIN) followed by insertion of an additional SIINFEKL tag at the N-terminus end of the GE sequence. (B)
Representative results from flow cytometry analysis of SIINFEKL presentation on 293Kb cells 48h after transfection with the indicated constructs.
Numbers in red boxes indicate percent of H-2Kb-SIINFEKL-positive cells within eGFP+ cells. (C) Percent of eGFP+ cells expressing H2-Kb-SIINFEKL
complexes at the cell surface based on the analysis in B. Bars show mean ± S.D. (n = 3). Statistical analyses by one-way ANOVA and Dunnett’s post-test
with SIIN as control comparison mean (*p0.05, ***p0.001).
https://doi.org/10.1371/journal.ppat.1006691.g005
aLANA immune evasion
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observations that could be associated with increased presentation of an endogenous epitope
(Fig 4). To explore this possibility, we treated transfected 293Kb cells with citrate buffer to
strip MHC-peptide from the cell surface, followed by incubation with CHX to inhibit de novo
protein synthesis (Fig 9A). Combined treatments significantly reduced the proportion of cells
expressing the MHC-peptide complexes at the cell surface irrespective of the presence or
absence of repeat regions (Fig 9B). In contrast, CHX treatment alone had only a minimal effect
Fig 6. Rescued antigen presentation of OVA-peptide in absence of GE-rich domain is dependent on proteasomal degradation and absence of GE
does not destabilize aLANA. (A) 293Kb cells were transfected with the different indicated constructs and treated 48h later with the proteasome inhibitor
MG132 (20 μM) or vehicle (DMSO) for 16h before analysis by flow cytometry of H-2Kb-SIINFEKL complexes expression at the cell surface. (B) Flow
cytometry analysis of H-2Kb-SIINFEKL expression in eGFP+ 293Kb cells 24h after transfection with SIIN, aLANA-SIIN or ΔGE-SIIN expression plasmids and
treated during 16h with MG132 (20 μM), lactacystin (10 μM), epoxomicin (2 μM), rapamycin (20 μM), chloroquine (80 μM) or 3MA (10 mM). (C) Protein
stability upon CHX-chase. 293Kb cells transfected with SIIN, aLANA-, ΔCR-, or ΔGE-SIIN expression plasmids were treated with CHX (50 μM) 24h post-
transfection. Protein amounts were determined by Western blot analysis using anti-GFP antibody. (D) Protein stability upon HaloTag pulse-chase. 293Kb
cells were transfected with the different indicated HaloTag (HT2) constructs during 48h, then pulsed with HaloTag TMR-Direct Ligand overnight, extensively
washed and chased for 72h. Fluorometry analysis was performed at the indicated time points. Bars show mean ± S.D. (n = 3). Statistical analyses by one- (A)
or two-way (B,D) ANOVA and Tukey’s (A) or Dunnett’s post-test with DMSO (B) or aLANA-HT (D) as control comparison mean (*p0.05, ***p0.001).
https://doi.org/10.1371/journal.ppat.1006691.g006
aLANA immune evasion
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Fig 7. The GE-rich domain reduces protein synthesis efficiency of aLANA. (A) Immunoblot analysis of expression of aLANA-, ΔCR-, ΔGPE- and
ΔGE-SIIN. 293Kb cells were transfected with the indicated plasmids and immunoblot performed at 48h after transfection. Duplicate blots were probed with
either HRP-anti-GFP monoclonal antibody to detect aLANA constructs or anti-actin monoclonal antibody as loading control. Band intensities from the
immunoblot were quantified by densitometry analysis using ImageJ64 software. Data are representative of three independent experiments with similar
results. (B) Flow cytometry analysis of eGFP median fluorescence intensities (MFI) at the indicated time points after transfection. The left panel shows
percent of eGFP+ cells and the right panel shows deltaMFI (dMFI). dMFI were calcutated as [MFI of eGFP-positive population–MFI of eGFP-negative
population]. (C) Halotag pulse-chase. Cells were transfected with aLANA- or ΔGE-HT2 constructs and pulsed 12h later with HaloTag TMR-Direct Ligand
overnight, extensively washed and chased for 24h. At the indicated time points, cells were incubated with cell-permeable HaloTag Oregon Green (OG)
Ligand for 15 min before analysis by flow cytometry for detection of de novo protein expression. (D) Uncoupled in vitro transcription/translation assay of
aLANA, ΔCR-, ΔGPE- and ΔGE-SIIN. The T7 promoter was first subcloned into the different peGFP-C1 constructs downstream the CMV promoter. The
constructs were then transcribed in vitro with T7 RNA polymerase. Equimolar amounts of the resulting capped RNAs were then subjected to in vitro
translation using rabbit reticulocyte lysate supplemented with [35S]-methionine. Intensities of the bands at the expected size obtained from immunoblotting in
A were quantified by densitometry analysis using ImageJ64 software. Braces indicate radioactive signal from parasite bands. (E) Immunoblot analysis of
SIIN, aLANA-SIIN, and GE-SIIN expression. 293Kb cells were transfected with the indicated plasmids and immunoblot performed at 24h after transfection.
Duplicate blots were probed with either HRP-anti-GFP monoclonal antibody to detect aLANA constructs or anti-GAPDH monoclonal antibody as loading
control. Band intensities from the immunoblot were quantified by densitometry analysis using ImageJ64 software. Data are representative of two independent
experiments with similar results. Statistical analyses by two-way ANOVA and Sidak’s post-test (***p0.001).
https://doi.org/10.1371/journal.ppat.1006691.g007
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on antigen presentation. Finally, citrate buffer treatment alone showed a differential effect on
293Kb expressing either aLANA or ΔCR and ΔGE, suggesting a more rapid antigen processing
by MHC-I in absence of CR and GE. These results revealed an association between translation
efficiency (and production of DRiPs) and antigen presentation.
Fig 8. The GE-rich domain reduces mRNA transcription levels without affecting RNA stability. (A)
Quantitative RT-PCR of aLANA-, ΔCR-, ΔGPE- and ΔGE-SIIN RNA extracted from 293Kb cells 48h after
transfection with the different constructs and subjected to cDNA synthesis using oligo(dT) primers and
quantitative PCR to detect ORF73 transcripts. (B) mRNA expression levels of aLANA-, ΔCR-, and ΔGE-SIIN
after transcription inhibition. 293Kb cells were transfected with the indicated constructs and treated 48h later
with actinomycin D to inhibit de novo transcription. Quantitative RT-PCR was then performed on total RNA
extracted at the indicated time-points to detect ORF73 transcripts. Bars show mean ± S.D. (n = 3). Statistical
analyses by one- (A) or two-way (B) ANOVA and Dunnett’s post-test with aLANA-SIIN as control comparison
mean (***p0.001).
https://doi.org/10.1371/journal.ppat.1006691.g008
Fig 9. Effect of MHC-peptide stripping and cycloheximide treatment on antigen presentation. (A) 293Kb cells were transfected with aLANA-, ΔCR-,
and ΔGE-SIIN constructs. At 24h post-transfection, cells were left untreated, treated with citrate phosphate buffer (pH 3), CHX (50μM), or treated with both
citrate buffer and CHX. (B) The levels of H2-Kb-SIINFEKL complexes expressed at the cell surface were then analyzed using an APC mouse anti-H2-Kb-
SIINFEKL complex (25-D1.16). Data represent the levels of H2-Kb-SIINFEKL complexes relative to untreated cells. Bars show mean ± S.E.M (n = 3).
Statistical analyses by two-way ANOVA and Tukey’s post-test (*p0.05, **p<0.01, ***p<0.001, ns, not significant).
https://doi.org/10.1371/journal.ppat.1006691.g009
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GE mRNA nucleotidic sequence regulates antigen presentation
Purine-rich GAr mRNA structure of EBNA1 regulates EBNA1 synthesis and presentation of
EBNA1 to specific T cells [41–43]. Analysis of the nucleotidic sequence of the aLANA GE
domain showed a bias towards usage of codons containing purines, with 100% of glutamate
residues and 81% of glycine residues being purine codons (GAA, GAG and GGA) (S5A and
S5B Fig) [27]. Prediction of mRNA secondary structure using Mfold revealed unstable second-
ary structures (S5C Fig). Thus, a codon-modified GE sequence (GEm) was synthesized in
order to reduce purine bias, while conserving the identical peptidic sequence (S5A Fig). Modi-
fication of the codon usage resulted in increased stabilization of mRNA secondary structure
reflected by the significantly more negative Gibbs free energy value (δG) of -153.91 kcal/mol
compared with -43.39 kcal/mol for the native GE form (S5C Fig). We hypothesized that purine
bias in aLANA GE mRNA sequence might be responsible for reduced antigen presentation.
Pairwise mRNA sequence alignment of aLANA or aLANA-GEm with EBV EBNA1 demon-
strated that the high sequence homology of aLANA GE with EBNA1 GAr sequence was lost
after codon modification in GE (S5D Fig) [27]. Synthetic GEm sequence was used to replace
the native GE in aLANA and generate the codon-modified aLANA-GEm (Fig 10A). Transfec-
tion of 293Kb cells aLANA-GEm-SIIN resulted in nuclear expression and significantly
enhanced proportion of H2Kb-SIINFEKL expressing cells compared to native aLANA-SIIN
(Fig 10B and 10C). Although the modification of the codon usage to reduce purine bias in
GEm did not result in antigen presentation as high as observed in absence of GE (ΔGE-SIIN),
our results suggest that constraints in native GE mRNA structure can limit antigen presenta-
tion. We further addressed this hypothesis by immunizing C57BL/6J mice using a DNA
immunization protocol [21]. DNA immunization with GEm-SIIN expressing plasmid resulted
in significantly increased SIIN-specific CD8+ T cells in peripheral blood compared to native
aLANA-SIIN construct (Fig 10D–10G). These results demonstrated that mRNA constraints in
GE limit antigen presentation and T cell priming.
The absence of GE in aLANA does not impair MCF induction in rabbits
We previously showed that MCF is caused by the lymphoproliferation of latently infected cells
expressing high levels of aLANA [21]. Here, we observed that the absence of GE in aLANA
resulted in increased presentation of an epitope linked to the protein (Fig 3). Based on previ-
ous reports showing that CTLs specific to EBNA1 or LANA1 could be detected in infected
patients [6–8], that the EBNA1 GAr domain was dispensable for episome maintenance and
immortalization of B cells in vitro [23], and that mLANA immune evasion of CTLs was essen-
tial for viral persistence in the host [34], we hypothesized that the absence of GE in aLANA
might result in an enhanced CTL priming and impaired evasion of aLANA-specific CTLs. To
address this hypothesis, we generated a recombinant virus expressing a GE-deleted (ΔGE)
form of aLANA and its revertant (ΔGE-Rev) (S6A and S6B Fig). Viral growth in BT fibroblasts
was not affected by the absence of aLANA GE domain (S6C Fig). This was expected as viruses
impaired for aLANA expression had no growth defect [21]. We then infected rabbits intrana-
sally with the WT, ΔGE or ΔGE-Rev strains (105 PFU/rabbit). Rabbits infected with the ΔGE
virus developed hyperthermia, splenomegaly, lymphadenopathy and expansion of CD8+ T
cells similar to the WT and ΔGE-Rev control groups (Fig 11). Lymphoblastoid cell lines could
also be propagated from both ΔGE and ΔGE-Rev-infected animals (S7 Fig), suggesting that a
truncated form of aLANA lacking its GE region is able to maintain viral episomes. Together,
these results suggest that aLANA GE-mediated inhibition of antigen presentation in cis is dis-
pensable in MCF pathogenesis.
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Discussion
Wildebeest infection by AlHV-1 is persistent and nonpathogenic. Such an adaptation of the
virus with its host species likely results from a long evolutionary relationship. Understanding
the mechanisms acquired during coevolution by AlHV-1 to achieve such an adaptation in wil-
debeest and evade host immunity is important to develop strategies to target AlHV-1 latency
in particular and γ-HV latent infection in general. In addition, AlHV-1 episomal persistence
has been shown to be essential in MCF pathogenesis in susceptible species [21]. We have previ-
ously shown that a lack of aLANA expression rendered AlHV-1 unable to induce MCF, which
positioned latency at the core of MCF pathogenesis. In this context, immune evasion by
aLANA during MCF is likely of importance in the pathogenesis of this deadly disease. In the
present study, we have brought evidence that aLANA can strongly limit antigen presentation
and induction of antigen-specific cytotoxic T cell responses through a mechanism in cis
depending on its GE-rich domain. However, AlHV-1 infection of MCF-susceptible rabbits
induced MCF irrespective of the presence or absence of GE in aLANA.
We used transient expression of chimeric aLANA fusion proteins in a model of MHC class
I peptide presentation in order to test the ability of AlHV-1 latency protein to evade immune
detection. We observed a strongly reduced presentation of an epitope linked to aLANA. How-
ever, aLANA did not reduce antigen presentation in trans in co-transfection experiments.
These results demonstrated that aLANA is not efficiently processed to MHC class I. Most viral
maintenance proteins contain acidic repeat domains, such as for example the GAr domain of
EBNA1, that have been involved in inhibition of MHC-I antigen presentation in cis [22].
aLANA has a long CR domain and antigen presentation could be restored after deletion of the
entire CR sequence. We further investigated the role of subdomains within the CR region and
identified a GE-rich region that was essential to inhibit the presentation of a linked peptide.
Although subregions could be identified within the GE region, such as the GE1, E-rich and
GE2 domains, only a protein lacking the GE-rich domain as a whole could restore antigen pre-
sentation and CTL activation to the levels of control chimeric eGFP-SIIN protein. In addition,
we further observed that the transfer of GE to a heterologous eGFP-SIIN protein strongly
inhibited antigen presentation. These results were important as they suggest that aLANA anti-
genic peptides are not effectively processed to MHC-I and identified the GE region as being
sufficient to mediate immune evasion.
We observed that GE inhibits proteasome-dependent antigen presentation. Increased anti-
gen presentation with ΔCR and ΔGE mutant proteins could have potentially been explained by
increased susceptibility to proteasomal degradation. However, it was not the case as a lack of
CR or GE did not result in increased protein turnover in pulse-chase experiments. Although
the internal repeat region of several GMPs, including LANA1, EBNA1, and mLANA signifi-
cantly decreased protein turnover [33, 34, 44], the protein stability of saimiriine herpesvirus 2
(SaHV-2) ORF73 protein product was not influenced by the CR domain [31]. In addition, the
region of LANA1 CR domain that inhibits proteasomal degradation was not involved in the
Fig 10. Codon-modified GE-rich domain of aLANA increases OVA-peptide presentation. (A) Schematic description of the aLANA
expression constructs expressing either the native GE (aLANA-SIIN) or a codon-modified GE (aLANA-GEm-SIIN). (B) Representative
results from flow cytometry analysis of SIINFEKL presentation on 293Kb cells. Cells were stained with APC mouse anti-H2-Kb-SIINFEKL
complex (25-D1.16) 48h after transfection with the indicated constructs. (C) Percent of eGFP+ cells expressing H2-Kb-SIINFEKL complexes
at the cell surface based on the analysis in B. Bars show mean ± S.D. (n = 3). (D) DNA immunization experimental layout. Mice received
20 μg of aLANA-SIIN or aLANA-GEm-SIIN plasmids in each tibial cranial muscle for electroporation. (E) Representative results from flow
cytometry analysis of SIINFEKL-specific CD8+ T cells in peripheral blood at day 14 and in spleen at day 30 after the 2nd immunization.
Gated CD8+ T cells are shown. (F) Kinetics of SIINFEKL-specific CD8+ T cells in peripheral blood of immunized mice. (G) Percent of
SIINFEKL-specific CD8+ T cells in spleen at day 30 after the 2nd immunization. Statistical analyses by unpaired Student t-test (C and G,
*p0.05) or two-way ANOVA and Sidak’s post-test (F, n = 4 to 6, *p0.05, **p0.01, ***p0.001).
https://doi.org/10.1371/journal.ppat.1006691.g010
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inhibition of antigen presentation [32]. These data were supported by another study revealing
that the half-life of a polypeptide did not determine antigen presentation [45], suggesting that
protection from proteasomal degradation may not be sufficient to block antigen presentation.
Beside increased susceptibility to proteasomal degradation, several studies have shown that
translation efficiency of GMPs such as EBNA1 is an important mechanism to explain the lim-
ited cis-antigen presentation [23, 24, 27–29]. Such observations resulted from a number of
studies on EBNA1 over the last decade that showed that in spite of the inhibitory effect of the
internal GAr domain, CTL responses directed towards EBNA1 could be readily detected in
EBV seropositive individuals [7, 46, 47], and we could observe SIINFEKL-specific CTLs after
DNA immunization with aLANA-SIIN (Fig 10). This paradox was resolved following exten-
sive in vitro molecular analyses of the endogenous processing of EBNA1 indicating that CTL
epitopes from this protein were predominantly generated from newly synthesized DRiPs
rather than from the long-lived pool of stable EBNA1 in EBV-infected B cells [23, 26–28, 41,
47]. These observations have subsequently been further extended to demonstrate that the gen-
eration of DRiPs is intrinsically linked to the rate at which proteins are synthesized [23]. In the
present study, we observed that the GE domain could reduce the efficiency of protein synthesis
of aLANA, an observation that could be explained by a combination of increased translation
efficiency (using uncoupled in vitro translation) as well as increased steady-state RNA expres-
sion levels when aLANA is deleted of GE. These results suggested that the GE-rich domain
inhibits antigen presentation through regulation of both protein translation and RNA tran-
scription levels, leading to a reduced production of DRiPs. DRiPs have been suggested to be
the main source of viral antigens processed to MHC-I [48]. We therefore further hypothesized
that targeting the mechanism leading to DRiPs production could be valuable for aLANA to
ensure episome persistence during latency while avoiding detection from the immune system.
Using citrate buffer and CHX co-treatment to block de novo protein synthesis after MHC-pep-
tide stripping, we observed a significant reduction of detectable MHC-peptide complexes at
the cell surface irrespective of the presence or absence of repeat regions. Thus, we can suggest
that endogenous processing of CTL epitopes fused to the aLANA-ΔGE protein is not deter-
mined by its intracellular stability but rather by the rate at which newly synthesized polypep-
tides are produced.
Comparison of γ-HVs maintenance protein mRNA sequences revealed the presence of
highly homologous purine-rich central repeat sequences [27]. Although highly conserved in
mRNA sequence, these repeat regions encoded very different peptide sequences in the differ-
ent viruses. In EBNA1, frame-shifting of the repetitive region without modifying the func-
tional N- and C-terminal region did not significantly modify the reduced self-synthesis and
the associated limitation in cis of antigen presentation. The purine-rich mRNA sequence
would therefore be responsible for the reduced expression of these viral mRNAs rather than its
encoded protein sequence. Interestingly, whereas the GE region of aLANA shares between
29.5 and 50% peptidic sequence homology with EBNA1 GAr region, the nucleotidic mRNA
sequence corresponding to the GE region has more than 70% sequence homology with GAr
and aLANA GE contains 96.6% purines. Codon modification of EBNA1 GAr sequence in
order to reduce the purine-bias led to increased protein translation and improved CTL
Fig 11. Malignant catarrhal fever induction. (A) Body temperature of 4 groups of rabbits infected intranasally with WT, ΔGE or ΔGE-Rev virus
strains (105 PFU/rabbit, n = 4). One group received the vehicle medium (Mock, n = 3). (B) Cumulative incidence of MCF induction in rabbits of the
different groups (n = 4). (C) Tissue mass of spleen and popliteal lymph nodes (pLN) at the time of euthanasia. (D) Percentages of CD8+ cells in the
gated T cell population analyzed by flow cytometry at regular intervals throughout the experiment. (E) Viral genome copy number in PBMC over
time after infection. Bars represent mean ± SEM with symbols showing individual measurements. Statistical analyses by log-rank test (B) and one-
way ANOVA and Dunnett’s post-test with Mock as control comparison mean (C).
https://doi.org/10.1371/journal.ppat.1006691.g011
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priming [26, 28]. We hypothesized that reducing the purine bias in the nucleotidic sequence
of the GE region in aLANA would result in a better presentation of the epitope linked to it.
Whereas both native aLANA and aLANA-GEm encode exactly the same protein, codon modifi-
cation in GEm mRNA resulted in a significant increase of antigen presentation. Although the
increased antigen presentation observed in vitro did not reach the levels obtained with a con-
struct lacking GE, immunization of C57BL/6 mice with aLANA-GEm lead to the activation of
significantly more antigen-specific CTLs (Fig 10). Inhibitory G-quadruplex structures were iden-
tified within EBNA1 nucleotidic sequence and are suggested to act as steric blocks to cause a
stalling/dissociation of ribosomes, therefore reducing translation efficiency. Although G-quadru-
plex structures could also be predicted within aLANA central repeat [43], it is possible that the
modification of the codon usage within GE was not sufficient to completely disrupt G-quadru-
plexes function for effective antigen presentation in vitro but sufficient to significantly increase
cross-priming of specific CTLs in vivo. Further analyses are required to determine the presence
of such structures in GE and their potential role in the cis-acting immune evasion of aLANA.
A rapid priming of an effective adaptive cellular immune response can determine the out-
come of primary infection and also the control of persistent viral infections [49]. Infection of
rabbits with a virus strain expressing a truncated form of aLANA lacking GE did not impair
MCF induction. We previously showed that aLANA expression was essential for viral persis-
tence and episomal maintenance during MCF. The present results suggest that the absence of
GE did not impair episomal maintenance, which was further supported by the effective propa-
gation of lymphoblastoid cells from rabbits infected by the ΔGE and ΔGE-Rev virus. The
absence of GE did not render the protein unstable in vitro (Fig 7). We could therefore expect
enhanced antigen-presentation by infected cells after infection with the ΔGE virus. Even
though such enhanced anti-aLANA specific response could exist, it is not sufficient to clear
proliferating infected cells and block the development of MCF lesions. A possible explanation
would be the expression during MCF of viral proteins involved in the inhibition of antigen
presentation by MHC-I in trans, though such proteins are yet to be identified in AlHV-1. This
observation is important in our understanding of other lymphoproliferative diseases induced
by γ-HV latent infection, where evasion mechanisms in trans could also be involved. However,
our lack of knowledge of the proteins involved in such mechanisms in AlHV-1 infection ren-
ders this hypothesis currently difficult to address. Even though a trans-acting mechanism is
possible, we have however previously shown that apart from aLANA-expressing ORF73, very
scarce gene expression could be detected during MCF [19], which could suggest alternative
immune evasion mechanisms developed by aLANA. Interestingly, EBNA1 was shown to be
protected from proteasomal degradation through a mechanism depending on its high avidity
for cellular DNA through the bipartite Gly-Arg repeat domains [50]. Potentially, similar
domains outside GE could similarly protect aLANA against proteasomal degradation and
therefore enable immune evasion in vivo. In addition, during KSHV and EBV lytic replication,
alternative cytoplasmic isoforms of LANA1 and EBNA1 are expressed [51, 52]. Interestingly, a
LANA1 isoform was shown to antagonize the innate immune DNA sensor cGAS [53].
Whether AlHV-1 also encodes such isoforms of aLANA and whether they can inhibit innate
immunity is unknown. Nonetheless, their expression during lytic replication could signifi-
cantly impair effective priming of aLANA-specific CD8+ T cells, thus potentially explain how a
ΔGE virus is able to persist in an immunocompetent host and induce MCF.
In this study, we provide evidence that aLANA has evolved mechanisms to evade CTLs by
inhibiting its own presentation in MHC-I through its central repeat purine-rich GE region
that self-regulates protein synthesis and antigen processing to MHC class I. Importantly, our
findings identify a key mechanism to evade immune surveillance by CTLs during AlHV-1
latency.
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Methods
Ethics statement
The experiments, maintenance and care of mice and rabbits complied with the guidelines of
the European Convention for the Protection of Vertebrate Animals used for Experimental and
other Scientific Purposes (CETS n˚ 123). The protocol was approved by the Committee on the
Ethics of Animal Experiments of the University of Liège, Belgium (Permits #1127, 1571 and
1598). All efforts were made to minimize suffering.
Cell lines and virus strains
293A cells stably expressing murine class I alleles H-2Kb or H-2Db (referred to as 293Kb and
293Db) were kindly provided by Dr Jonathan Yewdell (NIH/NIAID, USA) [36]. B3Z cells, an
H2-Kb-restricted CD8+ T-cell hybridoma, specific for the SIINFEKL ovalbumin peptide
(OVA254-264/Kb) and L929-Kb cells were obtained from Dr P.G. Stevenson (University of
Queensland, Australia). Bovine turbinate fibroblasts (BT, ATCC Crl-1390), bovine mammary
epithelial cells stably expressing the NLS-Cre (MacT-Cre, ATCC CRL-10274) [54], Vero
(ATCC CCL-81) and L929 (ATCC CCL-1) cells were cultured in Dulbecco’s modified essential
medium (DMEM, Sigma) containing 10% FCS. Madin Darby bovine kidney cells (MDBK,
ATCC CCL-22) were cultured in minimum essential medium (MEM, Sigma) supplemented
with 10% FCS. The pathogenic AlHV-1 C500 strain isolated from an ox with MCF (initially
obtained from Prof. D. Haig, University of Nottingham) and the AlHV-1 WT BAC clone were
used in this study [18, 55]. Viruses were maintained by a limited number of passages (<5).
Virus was amplified in BT cells before supernatants together with infected cells were concen-
trated by ultracentrifugation (100,000×g, 2h, 4˚C) and suspended in PBS before storage at
-80˚C. Samples were thawed, clarified (100×g, 20 min, 4˚C) and supernatants titrated by pla-
que assay as described previously [19].
Plasmids
The peGFP-C1 (Clontech) expression vector was used to clone the chicken ovalbumin epitope
SIINFEKL coding sequence into KpnI/BamHI sites using annealed oligonucleotides KpnI/
BamHI-SIIN-Fwd and KpnI/BamHI-SIIN-Rev (S1 Table) and T4 DNA ligase (Roche) to gen-
erate the peGFP-SIIN vector. AlHV-1 ORF73 coding sequence was amplified by PCR using
primers HindIII-73N-Fwd and KpnI-73CΔstop-Rev (S1 Table) and AlHV-1 BAC DNA as tem-
plate [18]. The obtained amplicon was then cloned into pGEM-T Easy vector (Promega) and
subcloned by ligation into peGFP-SIIN to generate the peGFP-aLANA-SIIN plasmid. Subse-
quent plasmid constructs, including those containing the ORF73 coding sequence deleted of
different subregions were generated either by ligation (T4 DNA ligase, Promega) or by homol-
ogous recombination using the In-Fusion HD cloning kit (Clontech) and primers listed in S1
Table. Plasmid vector peGFP-SIIN-aLANA was produced from peGFP-aLANA-SIIN after
replacement of the SIINFEKL peptide sequence by a stop codon and in-frame insertion of
SIINFEKL peptide sequence in N-terminus of ORF73 sequence. Plasmid vectors pT7-eGFP-
73Δx-SIIN were generated by sub-cloning the T7 promoter sequence downstream the CMV
IE promoter in the NheI site (S1 Table). Plasmid vector pEGFP-GE-SIIN was generated by
insertion of ORF73 GE-rich domain sequence into pEGFP-SIIN. An additional SIINFEKL
peptide sequence was further inserted in N-terminus of the GE sequence to create peGFP--
SIIN-GE-SIIN (S1 Table). Plasmid vector pEGFP-aLANA-GEm-SIIN was generated from
pEGFP-ΔGE1-SIIN. A pMK-RQ plasmid containing the synthetic GEm sequence (obtained
by codon-optimization– http://eu.idtdna.com/CodonOpt –and further empirically modified
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to enrich in pyrimidines, then synthesized by GeneArt, Life technologies) was digested (PstI/
KpnI) followed by ligation into pEGFP-ΔGE1-SIIN. Then, the ORF73 N-terminus coding
sequence was inserted into KpnI restriction site of pEGFP-ΔGE1-SIIN (S1 Table). HaloTag
pHT2 expression vector (Promega) was generously provided by Prof. Fransen (KULeuven,
Belgium) and used to produce the p-aLANA-HT2, pΔCR-HT2 and pΔGE-HT2 plasmids. To
express eGFP-SIIN, aLANA-SIIN and ΔGE-SIIN constructs under control of the promoter
EF1-α, pEFIN3 expression vector was digested with XbaI and used for insertion of PCR ampli-
cons generated using the pEGFP-C1-based constructs as templates and primers EGFP-
pEFIN3-Fwd and SIIN-pEFIN3-Rev (S1 Table). Plasmid vector pEFIN3-Kb to generate the
VeroKb stable cell line was generated by insertion of H-2Kb PCR amplicon from pcDNA3.1-
H2Kb (gift from Dr. J. Yewdell) into the XbaI site of pEFin3. All construct sequences were ver-
ified before being used in transfection experiments. mK3 expression vector was generously
obtained from Dr P.G. Stevenson (University of Queensland, Australia).
Antigen presentation assays
293Kb, 293Db, VeroKb or L929-Kb cells (105 cells/well in 24-well plates) were transfected with
0.25 μg of plasmid using Fugene HD (Promega). For co-transfection assays, cells were co-
transfected with 0.25 μg of each plasmid DNA. MHC-I-peptide complexes were detected by
immunostaining using allophycocyanin (APC)-conjugated anti-mouse H-2Kb-SIINFEKL
complex (mouse IgG1, clone 25-D1.16, eBioscience) for 30 min on ice. Cells were incubated
and washed in FACS buffer (PBS containing 0.1% BSA and 0.09% NaN3) before acquisition.
Where indicated, transfected cells were treated with MG132 (Z-Leu-Leu-Leu-al), lactacystin,
epoxomycin (Sigma), rapamycin, chloroquine or 3MA (InvivoGen) during 16h before immu-
nostaining. Antigen presentation was assayed using B3Z cells (105 cells/well in 24-well plates)
co-cultured during 16h at 37˚C with 293Kb cells transfected 48h before. Total cells were then
lysed at −80˚C during 30min in lysis buffer (5mM MgCL2, 1% Nonidet P-40, 0.15mM Chloro-
phenol red-β-D-galactopyranoside (CPRG, Invitrogen) in PBS) to quantify β-galactosidase
activity. Each cell lysate replicate was then divided in 2 wells of a 96-well flat-bottom plate and
incubated at 37˚C during 20h. β-galactosidase activity was measured using a spectrophotomet-
ric determination of absorbance at 595 nm using an iMark microplate reader (Biorad).
Confocal microscopy analysis
293Kb cells (2.5x105 cells/well in 12-well plates) were grown on poly-D-lysine coated glass cov-
erslips and transfected with 1 μg of plasmid using Fugene HD (Promega). Transfected cells
were stained 20 min at room temperature with an anti-mouse H-2Kb-SIINFEKL complex
(25-D1.16, eBioscience), washed and then incubated 1h at 37˚C with secondary Alexa Fluor
568 goat anti-mouse IgG polyserum (Life technologies). Cells were then washed and fixed in
4% paraformaldehyde in PBS before being mounted in ProLong antifade reagent (Life technol-
ogies). Washing and incubation steps were done in PBS containing 10% FCS. Fluorescence
was then visualized with a Leica confocal scanner (TCS) SP laser scanning microscope.
Western blotting
293Kb cells (5×105 cells/well in 6-well plates) were transfected with 2μg of plasmid and Fugene
HD (Promega). Cells were lysed after 24h in 100μL RIPA buffer (25mM Tris•HCl pH 7.6,
150mM NaCl, 1% Nonidet P-40, 1% sodium deoxycholate, 0.1% SDS). Lysates were heat-dena-
tured (95˚C, 5 min) before SDS-PAGE in laemmli buffer (31.25 mM Tris-Hcl pH 6.8, 1% (w/
v) SDS, 12.5% (w/v) glycerol, 0.005% (w/v) bromophenol blue, Biorad) containing 10% (v/v)
β-mercaptoethanol. Proteins were separated by electrophoresis in Mini-PROTEAN TGX
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precast 4–15% resolving gels (Biorad) in Tris-glycin running buffer (25mM Tris-base, 192mM
glycine, 0.1% w/v SDS) and transferred onto polyvinylidene difluoride membranes (PVDF,
Thermo Fisher Scientific, 0.45 μm pore size). The membranes were blocked with 3% skimmed
milk in PBS/0.1% Tween-20. For detection of eGFP fusion proteins, membranes were blotted
with HRP-conjugated anti-GFP antibody (mouse IgG1 mAb, 5000× diluted, Miltenyi Biotec).
Mouse anti-β-actin (Dako) and anti-GAPDH (Abcam, GA1R) monoclonal antibodies were
used with secondary HRP-conjugated rabbit anti-mouse polyserum (Dako). Rabbit anti-c-
Myc polyserum (Sigma) was used with HRP-conjugated goat anti-rabbit polyserum (Dako).
Novex Sharp pre-stained protein standard (Thermo Fischer) was used to determine band
sizes. Chemiluminescent reaction was performed with ECL substrate (GE Healthcare) and
membranes exposed onto an X-ray film.
RNA extraction, cDNA synthesis and quantitative PCR
293Kb cells (2.5x105 cells/well in 12-well plates) were transfected with 1 μg of plasmid using
Fugene HD (Promega). Total RNA was extracted 24h after transection using RNeasy Miniprep
kit (Qiagen) with on-column DNase I treatment. First-strand cDNA was then synthesized
using oligo-dT and Superscript III Reverse transcriptase system (Life technologies). Control
lacking reverse transcriptase was performed for each RNA sample to monitor DNA contami-
nation. Quantitative real-time PCR reactions (qPCR) were performed in iQ-SYBR green
supermix using a CFX96 Touch Real-Time PCR Detection System (Bio-Rad). Standard curves
were generated using specific PCR amplicons and the obtained copy numbers were normal-
ized to hypoxanthine-guanine phosphoribosyltransferase (HPRT) housekeeping gene (S2
Table). Where indicated, transfected cells were treated with actinomycin D (Sigma) during
4.5h before RNA extraction.
Uncoupled in vitro transcription/translation
Capped RNAs were transcribed in vitro from AvrII-linearized pT7-eGFP-73Δx-SIIN plasmids
using T7 RNA polymerase and mMessage mMachine kit (Ambion). Next, molar equivalents
were used for uncoupled in vitro translation using a rabbit reticulocyte lysate system (Pro-
mega) and [S35]-methionine (Perkin Elmer). Translation reaction products were separated by
SDS-PAGE before the gel was dried and exposed to an Amersham Hyperfilm MP (GE
Healthcare).
HaloTag pulse-chase assays
Pulse-labelling of live cells expressing HaloTag-fusion proteins was performed overnight at
12h post-transfection using cell-permeable HaloTag TMR-Direct Ligand (5μM, Promega).
Cells were then extensively washed with warm PBS and chased in phenol red-free standard
growth medium for the indicated period. At various time points, the fluorescence signal was
measured using an EnSpire multimode plate reader (Perkin Elmer). In some experiments,
pulse-labeled cells were further incubated at various time points of the chase period with cell-
permeable HaloTag Oregon Green Ligand (5μM, Promega) during 15min at 37˚C followed by
analysis by flow cytometry.
Cell surface MHC-peptide stripping and inhibition of de novo protein
synthesis
To strip MHC-epitope complexes from the surface of 293Kb cells, cells were detached 48h
post-transfection, washed with PBS and suspended in citrate phosphate (pH 3) buffer (0.131
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M citric acid, 0.066 M Na2HPO4) for 2 min on ice [56]. The suspension was then neutralized
with a 100-fold dilution of growth medium, and cells were washed twice. Then, cells were sus-
pended in growth medium and incubated in the presence or absence of 100μg/ml CHX for 5 h
(Sigma). Antigen presentation was assessed by flow cytometry analysis using anti-mouse H-
2Kb-SIINFEKL complex monoclonal antibody.
Virus mutagenesis
The AlHV-1 BAC clone was used to produce the recombinant plasmids using the galactoki-
nase gene (galk) as selection marker in SW102 E.coli strain [21]. To generate the BAC ΔGE
plasmid, a BAC ΔGE-galK plasmid was first produced by positive selection in presence of an
amplicon obtained by PCR using the pgalK vector as a template, the forward chimeric primer
H1ΔGE-galK-Fwd and the reverse chimeric primer H2ΔCR-galK-Rev (S3 Table). The ampli-
con consisted in the galK sequence flanked by 44-bp sequences corresponding to the regions
directly flanking the GE region of the AlHV-1 ORF73 (access no.: Refseq NC_002531, nt
117121–117170 and 117948–117991) in the viral genome. Full deletion of the GE region was
further achieved by galK negative selection using annealed oligonucleotides H1H2-ΔGE-Fwd
and H1H2-ΔGE-Rev. Finally, the BAC ΔGE-Rev plasmid was produced using two sequential
steps consisting in the re-introduction of the galK sequence using the ΔGE-galK amplicon
before negative selection performed in presence of the ORF73 full length fragment obtained by
SacI digestion of the pEGFP-aLANA-SIIN plasmid (S6 Fig). All deletions and insertions were
further verified using restriction endonuclease and Southern blot approaches and sequencing
of the recombination sites. All strains were reconstituted in MacT-Cre cells before propagation
in BT cells.
Southern blot
Southern blotting analysis was performed as described previously [19].
Growth curves
In vitro growth kinetics of recombinant viruses were compared to those of the WT. Cells were
infected (moi = 0.05) and both supernatants and infected cells were harvested at successive
intervals. The total amount of infectious viral particles was determined by plaque assay on
MDBK cells as described previously [19].
MCF induction
Four groups of specific pathogen-free New-Zealand white rabbits (n = 4) were used. Animals
were inoculated intranasally with 105 PFU of the different AlHV-1 recombinant viruses in PBS
or PBS only for the mock-infected group. Rabbits were examined daily for clinical signs.
According to bioethical rules, rabbits were euthanized when rectal temperature remained
higher than 40˚C for two consecutive days.
Leukocytic cell suspension preparation
PBMC were isolated from 5-ml of blood collected from the ear central artery before and at dif-
ferent time-points after infection. Immediately after euthanasia, single-cell suspensions were
prepared from popliteal lymph node (pLN) and spleen as follows. Tissue biopsies were del-
icately chopped in sterile RPMI media and passed through a 70 μm cell-strainer (BD Biosci-
ences). Mononuclear leukocyte suspensions from peripheral blood and tissue samples were
prepared with Ficoll-Paque Premium density gradient media (GE Healthcare). 5-ml single-cell
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suspension was diluted 1:1 in sterile PBS, overlaid onto 5-ml Ficoll-Paque density cushion and
centrifuged (1825×g) during 20-min at room temperature. Mononuclear leukocytes at the
interface were collected and washed in ice-cold PBS before further analysis.
DNA immunization
8-week-old female C57BL/6 mice were subjected to DNA immunization as described previ-
ously [21]. Briefly, 20 μg of plasmid construct in 25 μL of PBS were electroporated in both
hind legs at day 0 and 14 in the tibial cranial muscle. Blood sampling were taken at d0, 7, 14
and 27 before euthanasia and spleen harvested at d30.
Antibodies and flow cytometry
Multi-color flow cytometry analysis of rabbit PBMC was performed as described previously
[20]. Briefly, cells were incubated in FACS buffers (PBS containing 0.1% BSA, 0.09% NaN3)
with mAb anti-rabbit CD4 (IgG2a, KEN-4), CD8 (IgG1, 12C.7), IgM (IgG1, NRBM) antibody
cocktail and left on ice for 10min. Cells were washed and further incubated for 10min on ice
with isotype-specific PE-conjugated rat anti-mouse IgG1 (A85-1, BD) and biotinylated rat
anti-mouse IgG2a (R19-15, BD) antibodies. After a third wash, cells were incubated with
FITC-conjugated anti-rabbit T cells (KEN-5), and APC-conjugated streptavidin (BD) before
washing, staining with 7-AAD and acquisition. All antibodies were from AbD-Serotec-Biorad
or specified otherwise.
Following DNA immunization, blood samples were collected from mice at regular inter-
vals, lysed in ACK lysis buffer (Gibco) following the manufacturer’s instructions and incubated
in FACS buffer with mAb anti-mouse CD3 (APC, 145-2C11), CD8α (FITC, 53–6.7), CD44
(PE-Cy7, IM7). Antibodies were from BD Biosciences. Samples were further incubated with
H-2Kb-SIINFEKL tetramer (Brilliant violet 421nm, NIH Tetramer Core Facility).
Flow cytometry
Acquisitions were performed using a LSR Fortessa X-20 (BD Biosciences). A total of 50 to
100,000 live events were collected and data were analyzed by Flowjo v10.0.7 software
(Treestar).
Statistical analysis
Statistical analyses were conducted using Graphpad Prism v6 software (GraphPad, San Diego,
CA). Unpaired Student’s t test was conducted when comparing statistical difference between
two datasets. One or two-way ANOVA were conducted when comparing more than two
groups of data as indicated in the figure legends and followed by relevant post-test for mean
multiple comparison. Sidak’s method was used when comparing pairs of means within each
row, and Dunnett’s or Tukey’s methods were chosen for comparing every mean (3 or more
columns) within each row to one control mean or every mean with every other mean,
respectively.
Supporting information
S1 Fig. aLANA GE-mediated inhibition of antigen presentation. (A) 293Kb or 293Db cells
were transfected with the indicated constructs and stained 24h later for the detection of H-
2Kb-SIINFEKL complexes on the cell surface. Numbers in bold indicate the percent of H-2Kb-
SIINFEKL-positive cells within eGFP+ cells (n = 3). (B) L929-Kb cells were transfected with
eGFP, SIIN or aLANA-SIIN expression vectors and stained 48h later for detection of H-2Kb-
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SIINFEKL-positive cells (n = 3 to 9). (C) VeroKb cells stably expressing the mouse H-2Kb hap-
lotype were generated using the pEFIN3-Kb plasmid construct as detailed in the methods and
selection was performed using geneticin (250 μg/mL). VeroKb cells were used without further
cloning and transfected with the indicated constructs and stained 24h later for the detection of
H-2Kb-SIINFEKL complexes on the cell surface. Representative plots are shown and numbers
in boxes indicate the percent of H-2Kb-SIINFEKL-positive cells within eGFP+ cells. (D) 293Kb
cells were transfected with pEFIN3-SIIN, -aLANA-SIIN, or -ΔGE-SIIN and analyzed 24h later
for the expression of H-2Kb-SIINFEKL complexes. Numbers in boxes indicate the percent of
H-2Kb-SIINFEKL-positive cells within eGFP+ cells. Bar graph show the percent of eGFP+ cells
expressing H-2Kb-SIINFEKL complexes. Statistical analyses by two-way (A) or one-way
ANOVA (B,D) and Dunnett’s post-test with eGFP (A), SIIN (B) or aLANA-SIIN (D) as con-
trol comparison mean (p0.01, p0.001).
(TIF)
S2 Fig. Epifluorescence microscopic analysis of expression of fusion proteins in 293Kb
cells 48h after transfection with the different constructs. Nuclear DNA is stained in blue
using 4’,6-diamidino-2-phenylindole (DAPI).
(TIF)
S3 Fig. Epoxomicin and lactacystin treatment. 293Kb cells were transfected and treated
24h later with the indicated concentrations of proteasome inhibitors during 16h. Cells
were then stained to detect surface H-2Kb-SIINFEKL complexes. The results show the percent
of eGFP+ cells expressing H-2Kb-SIINFEKL complexes.
(TIF)
S4 Fig. Western blot and in vitro translation assay. (A) eGFP-tagged proteins were detected
by western blot 24h after transfection. Loading of lysates was adapted in order to obtain detect-
able bands and determine the molecular weight of aLANA-, ΔCR-, ΔGPE- and ΔGE-SIIN pro-
teins. (B) In vitro translation assay. Original gel used to generate Fig 7D and illustrating how
the bands at the expected sizes were determined.
(TIF)
S5 Fig. Codon-modification of the GE-rich region of aLANA. (A) Sequence alignment
between the native GE and codon-modified GEm sequences. Matched and mismatched
nucleotides are depicted in blue and red, respectively. (B) Codon usage of native GE (GE),
codon-optimized GE obtained using CodonOpt (IDTDNA) (GEopt) and codon-modified GE
(GEm) sequences. (C) Prediction of mRNA secondary structures using Mfold of GE, GEopt
and GEm sequences. ΔG; Gibbs free energy value. (D) Dot-plot analysis illustrating pairwise
local alignement between EBV EBNA1 mRNA sequence and the mRNA sequence of aLANA
or aLANA-GEm. The overall homology is shown as a straight line on the diagonal, while
regions of homologous repeats are shown as lots of lines in the same region. Both EBNA1 GAr
and aLANA GE repeat mRNA sequences are identified using broken lines boxes. Alignements
were performed using zPicture (https://zpicture.dcode.org), a dynamic alignment and visuali-
zation tool based on the BLASTZ alignment program.
(TIF)
S6 Fig. Production of aLANA-ΔGE virus. (A) Schematic representation of the recombineer-
ing methodology used to produce the viral recombinant strains expressing truncated forms of
aLANA lacking the GE domain (ΔGE). (B) The produced BAC plasmids were analyzed by
Southern blotting after SacII restriction and ethidium bromide staining (EtBr). ORF73 probe
consisted in a 679-bp C-terminal region of ORF73 coding sequence. (C) Multi-step growth
aLANA immune evasion
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curves of WT, ΔGE, or ΔGE-rev virus strains in BT fibroblasts. The data presented are the
means ± SD of results from measurements in triplicates.
(TIF)
S7 Fig. Lymphoblastoid cell lines (LCLs) phenotypic analysis. LCLs were propagated from
peripheral blood mononuclear cells of rabbits developing MCF after infection with ΔGE or
ΔGE-rev viruses in Iscove’s modified Dulbecco’s medium (IMDM) containing 10% FCS and
supplemented with recombinant human interleukin 2 (Roche, 10 IU/mL). Cells were main-
tained in medium replaced every 3–4 days and analyzed by flow cytometry for IgM+ B cells,
CD8+ T cells and CD4+ T cells after 3 weeks culture (A). (B) Percent of CD8+ T cells in LCLs
based on analysis in A. (C) LCL cell counts over time in culture.
(TIF)
S1 Table. Oligonucleotides used in this study to produce aLANA and aLANA mutant
expression plasmids. Restriction sites in the primers sequences were highlighted in bold.
(PDF)
S2 Table. Oligonucleotides used in this study to perform quantitative PCR reactions.
(PDF)
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